Article Information
History
- March 2, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Andrea Sitlinger3,
- Michael A. Deal1,2,
- Erwin Garcia4,
- Dana K. Thompson5,
- Tiffany Stewart5,
- Grace A. MacDonald1,2,
- Nicolas Devos6,
- David Corcoran6,
- Janet S. Staats7,
- Jennifer Enzor7,
- Kent J. Weinhold7,
- Danielle M. Brander3,
- J. Brice Weinberg5 and
- David B. Bartlett1,2,*
- 1Division of Medical Oncology, Duke University School of Medicine, Durham, NC, USA
- 2Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, NC, USA
- 3Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC, USA
- 4Laboratory Corporation of America Holdings, Morrisville, NC, USA
- 5Division of Hematology, Duke University School of Medicine and VA Medical Center, Durham, NC, USA
- 6Duke Center for Genomic and Computational Biology, Duke University, Durham, NC, USA
- 7Division of Surgical Sciences, Duke University School of Medicine, Durham, NC, USA
- ↵*Corresponding Author: David B. Bartlett, PhD, Department of Medicine, Division of Medical Oncology, Duke Molecular Physiology Institute, Durham, North Carolina 27701, Phone: (919) 684-0622, Email: david.bartlett{at}duke.edu